Altimmune, Inc. (ALT)
Latest ALT Insider Trades
Jerome Benedict Durso - OfficerOpen-market purchase$44K
John GillOpen-market purchase$31K
About Altimmune, Inc. (ALT)
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
- GAITHERSBURG, MD
- 57
- 2005
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 1 | 15,000 | $44K |
| Grant or award | 2 | 2,628 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
ALT Insider Transactions (Form 4)
2146 Form 4 filings on record, the earliest from Nov 12, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Gregory L. Weaver - Officer | Grant or award | Stock Options (option to buy) |
Recent ALT Form 8-K Filings
5ALT Insider Trading - FAQ
What is the latest insider trade for ALT?
Altimmune, Inc. (ALT) had 3 insider filings in the last 90 days, with the most recent on 2026-08-13. The full record for ALT runs to 46 Form 4 filings, the earliest from 2024-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying ALT stock?
1 insider purchase of ALT was filed in the last 90 days, totaling $44K.
How many insiders are selling ALT stock?
No insider sales of ALT were filed in the last 90 days.
Where can I see ALT SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks ALT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow ALT insider buys?
Create a free InsiderAlpha account and press Watch on this page to add ALT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Jerome Benedict Durso view on EDGAR
- - Gregory L. Weaver view on EDGAR
- - M. Scot Roberts view on EDGAR
- - Teri L. Lawver view on EDGAR
- - Catherine A. Sohn view on EDGAR
- - Diane Jorkasky view on EDGAR
- - Klaus Schafer view on EDGAR
- - Wayne Pisano view on EDGAR
- - Philip Hodges view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where ALT's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track ALT insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
